Site-directed mutagenesis of the three binding sites for the mammary factor MPBF in the/I-lactoglobulin (BLG) promoter demonstrates that MPBF is a transcriotional activator of the BLG gene in mammarv cells. MPBF requires Dhosphorvlation on tvrosine for maximum binding activitv and binds to C&S (interferon y-activation sitejelements which ire similar to the hPBF binding sites. Prolaciin induces MPBF binding activity inCH0 cells and is not antigenically related to Stat1 (~91) and Stat2 (pll3), suggesting that this transcription factor is likely to be another member of the STAT family of cytokine/growth factor-induced transcription factors.
Introduction
Prolactin (PRL) is a peptide hormone that regulates the metabolism, proliferation and differentiation of a variety of cells and tissues [l] . In the mammary gland, PRL controls both development of the gland and the expression of milk protein genes [2] . The PRL receptor is closely related to the growth hormone (GH) receptor and is a member of the cytokine/GH superfamily of receptors that lack intrinsic tyrosine kinase activity [3] . Upon GH binding, the GH receptor associates with, and is phosphorylated by JAK2, a non-receptor protein tyrosine kinase (PTK), which is presumed to initiate the signal cascade that results in gene activation [4, 5] . The recent demonstration that JAK2 is also essential for both IFN [6] and PRL [7] signal transduction suggests that PRL action may be mediated through a member of the STAT family of transcription factors which are involved in IFN and cytokine signalling pathways (reviewed in [8] ).
The putative mammary transcription factor MPBF has three binding sites within the proximal 410 bp promoter of the sheep p-lactoglobulin (BLG) gene [9] . MPBF may be related to the transcription factor MGF which has been shown to be essential for the hormone induced transcription of a transfected B-casein promoter/ CAT construct in mammary HCl 1 cells [lo] . The highest affinity MPBF binding site GATTCCGGGAACC is similar to the IFN-y activation sequence (GAS) ATA-TTCCTGTAAGTG in the Ly-6E gene [l 1 J and shares an identical 9 bp core with a high affinity acute phase response factor (APRF) binding site [12] . This suggests that MPBF could be related to the IFN-)/ activated fac-*Corresponding author. Fax: (44) (31) 440-0434. We demonstrate here that MPBF is a transcriptional activator of the BLG gene in mammary cells. We also show that MPBF is induced in HCl1 cells in response to dexamethasone and PRL and in CHO cells in response to PRL alone. MPBF is not antigenically related to Stat1 or Stat2, but is phosphorylated on tyrosine and binds to GAS elements suggesting that it is probably a factor which mediates the response to prolactin.
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Materials and methods
BLG reporter constructs and plasmids
Individual MPBF binding sites in the BLG promoter were mutated as described ( [14] , T.B. et al., in prep.). The mutated BLG promoters were excised as Sal I/ SphI fragments and cloned 5' of the CAT gene in SalUSphI restricted CAT/pUC19 plasmid. The NFkB site at -172 in the BLG promoter was mutated using the same stategy as described for generating the MPBF mutations. Sequences of the mutant oligonucleotides are: STMm(sense) GGGATTTGGCCAACCGC; --STMm(antisense) GCGGTTGGCCAAATCCC; A3m(sense) GTCT--7 ACCACCAACCGTC; A3m(antlsense) GACGGTTGGTGGTA-GAC; Alm(sense) GTGTTCCTCCCACTGGC; Alm(antisense) GCCAGTGGGAGGAACAC;
NxBm(sense) GGCCCAGAG-EGACTTBTG;
NFkBm(antisense) CAGGAAGTCGAGCTCT-GGGCC The bases which have been changed are underlined.
CAT assays
Before harvesting, cells were washed with phosphate buffered saline, then scraped from the dishes in 10 mM Tris-HCl, pH 7.5,30 mM NaCl, 1 mM EDTA. Cells were pelleted by centrifugation and resuspended in 200~1 of 0.25 M Tris-HCl. Cytosol extracts were prepared by 3 cycles of freeze thawing [I 51 followed by centrifugation at 10,000 x g for 5 min. The protein concentration of the supernatants was estimated using the BCA protein assay (Pierce). CAT assays containing 1 pg of protein extract were carried out as described previously [15] and assayed using thin layer chromatography. The growth and hormonal induction of HCl I mammary cells was carried out as previously described [IO] . Approximately 5 x lo5 cells per 80 cm2 flask were cotransfected overnight with 1 pg of pSV2neo and 15 pug of BLG plasmid by calcium phosphate precipitation [15] . After 14 days of selection in growth medium containing 200 ,@ml G418, colonies were trypsinised and expanded as a pool of clones. Pools containing greater than 100 colonies were utilised in the hormone induction experiments. The CHO-E3 cell line is a clone derived from CHO-KI cells stably transfected with the rabbit long-form PRL receptor and was a kind gift from Jean Djiane, INRA, Jouy-en-Josas, France. CHO-E3 cells were induced in serum free medium with PRL as described previously [16] .
Nuclear extracts and EMSA
Nuclear extracts were prepared from tissues and cells using the method of Dignam [17] with minor modifications [9] . Aliquots were flash frozen in liquid nitrogen and stored at -80°C. Daudi cells (human lymphoma derived) were treated with 1000 units IFN-a/ml for 2 h before preparation of nuclear extract. Daudi extracts were generously provided by John Girdlestone, Laboratory of Molecular Biology, Cambridge. EMSAs were carried out as previously described [9] and where indicated, unlabelled oligonucleotide competitors were added simultaneously. Binding sites were created by annealing the following oligonucleotide pairs: STM GATTCCGGGkACCGC?
and ACGCI GGTTCCCGGAATC:
SIE GTCGACATTTCCCGTAAATC and TCGACGATTTACGGGAAATG;
GAS CATGTTATGCATATTC-CTGTAAGTG and CATGCACITACAGGAATATGCATAA; ISRE GATCGGGAAAGGGAAACCGAAACTGAAGCC and GATCGG-CTTCAGTTTCGGTTTCCCTTTCCC.
Supershift analysis was carried out essentially as above with prior incubation of antibody and nuclear extract for 30 min at 4°C plus 10 min at 25°C before the addition of probe. The Stat1 antibody was purchased from Transduction Laboratories and the Stat2 antibody was the gift of Chris Schindler, Columbia University, New York.
Phosphorylation studies of MPBF
Two protein tyrosine phosphatases were used, T-Cell, (NEB: a human T-cell tyrosine phosphatase) and LAR (NEB; the human transmembrane leukocyte antigen related tyrosine phosphatase). Sheep nuclear extract (250 ng) was incubated at 30°C for 20-60 min with 5 U of the T-Cell, (167 ng) or LAR (1.25 pg) phosphatase, after which EMSA was carried out on the extracts. Monoclonal anti-phosphotyrosine, anti-phosphoserine and anti-phosphothreonine antibodies (Sigma) or control mouse ascites fluid (2-5 pug) were incubated on ice for 90 min with approximately 100 ng partially purified MPBF (from sheep lactating mammary gland nuclei) in gel shift buffer and then analysed by EMSA.
UV cross-linking of MPBF
The double-stranded DNA probe used in the cross-linking experiment was prepared as described in Wakao [18] by annealing the singlestrand oligonucleotide that spans the STM binding site (TGGGATT-CCGGGAACCGCGTA(A),,) with a short primer (TTACGCGG). MPBF was cross-linked to the oligonucleotide probe by irradiation of an EMSA gel on a UV transilluminator for 2 min. To reduce the exposure times required to detect cross-linked proteins by autoradiography, electroelution was eliminated by incorporating the EMSA gel slice into the stacking gel of an SDS-PAGE gel [19] . Labelled polypeptides were detected by autoradiography of dried gels.
Quantitation
Data were quantitated with a Molecular Dynamics PhosphorImager system.
Results
MPBF is a transcriptional activator of BLG promoter constructs in mammary HCIl cells
Electrophoretic mobility shift assay (EMSA) with nuclear extracts prepared from hormonally induced HCl 1 cells and the high affinity STM binding site from the BLG promoter revealed a specific MPBF complex in HCl 1 cells. This MPBF-like activity was present at low levels in uninduced HCl 1 cells (Fig. 1 A, lane 1) and was induced 2-to 3-fold by treating cells with dexamethasone (DEX) and PRL (lane 2).
To determine the role of MPBF in the transcriptional regulation of the BLG gene in mammary cells, the 408 bp BLG proximal promoter sequence was mutated to abrogate MPBF binding at combinations of binding sites within a BLGKAT reporter gene construct. To abolish MPBF binding two guanine bases, shown to be essential for MGF binding by contact point analysis [lo] , were changed to cytosine in all three MPBF sites. This dramatically reduced MPBF binding to the Al and A3S MPBF sites (T.B. et al., in prep.); however, two additional bases, cytosines at positions -100 and -99 had to be changed to T and G, respectively, to completely eliminate MPBF binding to the high affinity STM site.
Three constructs were selected for analysis in HCl 1 cells: STM, in which the proximal STM site was changed; AlA3, in which the Al and A3S sites were modified; and SAA in which all thee MPBF sites were mutated. In addition, an NFlcB binding site at -172 which does bind an NFFcB-like activity in HCl 1 cells as judged by EMSA (data not shown), was also mutated using the PCR mutagenesis strategy (Fig. 1B) . The CAT activity generated by unmodified and mutated BLG promoter-CAT constructs was measured in cytoplasmic extracts from stably transfected HCll cells treated with either insulin or insulin, dexamethasone and PRL. The constructs were tested in three independently generated transfected pools of cells and the result of a representative experiment is shown in Fig. 1C . Whilst mutation of the NFlcB site did not affect expression of the BLG promoter, mutation of MPBF sites significantly reduced CAT activity. Mutation of MPBF sites in the BLG-CAT constructs did not completely abolish the 3-to 4-fold 8, 12 ), or 300-fold (lanes 5,9, 13) molar excess of the indicated cold oligonucleotide was added to the binding reaction and the amount of complex remaining relative to the uncompeted sample (lanes 1) quantitated with a phosphorimager.
affinity SIE (sis-inducible element) variant which binds SIF [20] , and a high affinity APRE site [12] which binds APRF (Stat3) shows that these sites have a degree of dyad symmetry with the sequence at five positions absolutely conserved (shown in bold in Fig. 2A ). Of the three BLG sites, STM is most similar to the GAS-related sequences, matching exactly at seven positions and is almost identical to the APRE variant motif. EMSA analysis showed that a mammary-specific complex of the same mobility as MPBF was observed with SIE and GAS oligonucleotide probes (data not shown). The relative affinity of MPBF for the STM, GAS, and SIE sites was determined by a competition EMSA in which either the STM or SIE elements were used as probe and all three binding site oligonucleotides were used as competitors (Fig. 2B) . Quantitation of the retarded probe indicated that the affinity of MPBF for both the SIE and GAS sites was approximately five-fold lower than for the STM oligonucloetide. The affinity of MPBF for the GAS and SIE sites was similar to that for the BLG intermediate affinity A3S site (5 to 6-fold lower affinity than STM) but considerably higher than for the BLG Al motif (44-fold less than STM, [9] ). MPBF did not bind an IFN-cr response element (ISRE) as judged by EMSA (Fig. 5B) indicating that MPBF recognises only a particular class of cytokine/growth factor response elements and suggests that MPBF may be related to the STAT family of transcription factors that bind GAS/SIE related sequences.
MPBF is phosphorylated on tyrosine
To test whether MPBF requires tyrosine phosphorylation for DNA binding activity, nuclear extracts from sheep and mouse lactating mammary gland were treated with either protein tyrosine phosphatases or with antiphosphotyrosine antibodies and analysed by EMSA. Treatment with either human T-cell or leukocyte antigen related (LAR) protein tyrosine phosphatase prior to EMSA reduced MPBF binding activity by 95% and 86% in mouse (Fig. 3A, lanes 5-9) and sheep (lanes 14) extracts respectively, and was inhibited by the specific tyrosine phosphatase inhibitor, sodium vanadate (lanes 2, 4, 6 and 8)). Antibodies directed against phosphotyrosy1 residues, also inhibited MPBF activity in partially purified sheep mammary nuclear extract by over 85% (Fig. 3B, lanes 2 and 3) . Preimmune serum (lane l), antiphosphoserine (lane 4) and antiphosphothreonine (lane 5) antibodies did not inhibit MPBF complex formation under these conditions. These results indicate that tyrosine phosphorylation of MPBF or a component of the MPBF complex is required for maximal DNA binding activity. 
Stat1 and Stat2 are not components of MPBF
Antibody binding experiments coupled with EMSAs were carried out to determine whether Stat1 and Stat2 are components of the MPBF binding complex. Nuclear extract from lactating human mammary gland was used in these experiments to allow a direct comparison with the Stat 1 and ISGF-3 complexes induced by IFN-a treatment of Daudi cells. Nuclear extracts were incubated with antibodies specific for either Stat1 or Stat2 before EMSA with either STM or an ISRE (IFN-a stimulated response element) probe. The Stat 1 and Stat2 antibodies inhibited complexes formed on the GAS and ISRE probes respectively in Daudi nuclear extracts but did not affect binding of human MPBF (Fig. 5, lanes l-9) . In addition, the mobilities of the MPBF and Stat1 complexes are clearly different. Western blots of nuclear extracts also indicated that mammary nuclei contain very low levels of Stat1 (data not shown) supporting the conclusion that Stat1 and Stat2 are not components of MPBF which may be a novel member of the STAT family.
MPBF-like binding activity is induced directly by prolactin
To determine whether PRL could induce MPBF binding activity we utilised Chinese hamster ovary (CHO-E3) cells stably transfected with a vector that expresses the long form of the rabbit PRL receptor. This system has been used to demonstrate that the BLG promoter is stimulated by PRL [16, and lOO-fold excess (lanes 5, 8). Lane 9 is an MPBF control using 8pg nuclear extract from lactating mouse mammary gland. This track was exposed for a shorter time than lanes I-8.
the prolactin response elements in the BLG promoter (Demmer et al., in prep.). A factor of similar mobility to mouse MPBF was induced 5-to IO-fold in the nuclear extracts of CHO-E3 cells treated with PRL. This factor bound the STM oligonucleotide specifically as demonstrated by titration with cold STM competitor binding sites. Competition with the SIE oligonucleotide demonstrated that the induced factor had a reduced affinity for this site compared with the STM oligonucleotide, analagous to the the result obtained with mammary gland derived MPBF (Fig. 2B) . These results show that an MPBF-like binding activity can be stimulated by PRL alone and may mediate PRL signalling in tissues and cells other than the mammary gland.
Discussion
MPBF has several characteristics of the recently described STAT family of transcription factors. MPBF recognises Stat 1 binding sites, requires tyrosine phosphorylation for DNA binding and may be composed of a dimer of an 80-90 kDa polypeptide.
Five members of the STAT family of signalling factors have been cloned so far. In addition to Stat1 and Stat2, cDNA clones of mouse and human APRF (Stat3), mouse Stat4 and sheep MGF have been identified [22, 23, 24] . Although the highest affinity binding site for MPBF, STM, is almost identical to a high affinity variant of the APRF recognition element ([ 121 and Fig. 1 A) preliminary supershift experiments with an antibody to APRF indicate that MPBF does not contain Stat3 (data not shown). Since MGF has been shown to mediate the response to PRL and has binding sites in the promoter of the B-casein milk protein gene, it is likely that MGF and MPBF are similar factors.
The finding that MPBF binds other STAT factor recognition sequences suggests that STAT factors might regulate the BLG promoter through its MPBF sites. EGF is known to inhibit the expression of milk protein genes and can interfere in the induction of MGF in HCl 1 cells [26] but the mechanism through which this effect is mediated is unknown.
Since EGF can induce Stat 1 and Stat3, it is possible that these factors could directly antagonise milk protein gene expression by binding to MPBF and MGF sites. The identification of an MPBFlike complex in the virgin and early pregnant sheep mammary gland (CJW and TB, unpublished results), when the BLG gene is inactive, suggests that such a repressor might operate in vivo.
Stat1 is the paradigm for a growing family of transcription factors which can be posttranslationally activated in response to cytokines and growth factors. It will be interesting to determine the role these factors play in the regulation of mammary gland development and milk protein gene expression.
